Drug Approval | November 22, 2021
Amneal gets approval for Difluprednate ophthalmic emulsion
The company is moving towards complex and more differentiated products
The company is moving towards complex and more differentiated products
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
This test is inexpensive and results are available immediately as compared to the genetic test
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
Evidence also shows better immune response to virus among users of spray
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
Ivenix selected Tritan MXF for the pump exterior because of its excellent chemical resistance and durability in the face of the aggressive disinfection protocols needed to prevent the spread of healthcare-associated infections
Subscribe To Our Newsletter & Stay Updated
